Bronx Trialed Drug, Remdesivir: Part of President’s Treatment for COVID-19
President Donald Trump’s doctors said during a press briefing on Oct. 3, that the president is being administered remdesivir, a drug trialed in the Bronx to treat patients with COVID-19, as a joint research initiative by Montefiore Health System and the Albert Einstein College of Medicine. Einstein/Montefiore was the first New York site to take part in what is an ongoing international drug treatment study. The first iteration of the Adaptive COVID-19 Treatment Trial (ACTT) began in various locations on Feb. 21, though candidate recruitment only began in the Bronx in March. Remdesivir is described as an investigational, broad-spectrum
